NeuroD1, the vertebrate ortholog of
cnd-1, is a basic-Helix-Loop-Helix protein involved in neuronal and pancreatic beta cell fate specification. NeuroD1 loss-of-function mutations have been implicated in human visual impairment, learning disabilities, deafness, and neonatal diabetes. In C. elegans,
cnd-1 is expressed in many unidentified head neurons and also in D-class motor neurons. Only three genes are known to act downstream of
cnd-1 in C. elegans;
unc-3,
unc-4, and
unc-30. All three of these genes are transcription factors that are expressed in D-class motor neurons. However, the remaining downstream targets of
cnd-1 have not been identified. In order to investigate the regulatory role of
cnd-1, we performed RNA-extractions from wildtype and
cnd-1 loss-of-function embryos, followed by RNAseq. We assembled a transcriptome outlining differentially expressed genes during embryogenesis and are currently following up by validating candidate
cnd-1 target genes using genetic approaches. In addition, NeuroD1 is known to function in a regulatory cascade with neurogenin and also to positively regulate itself in mammalian neuron specification. We seek to verify this relationship in C. elegans in order to better understand the regulatory context of our novel
cnd-1 target genes.